Suppr超能文献

优化连接体刚性以改善靶向造血前列腺素D合酶的PROTACs的细胞内行为。

Optimizing linker rigidity to improve intracellular behavior of PROTACs targeting hematopoietic prostaglandin D synthase.

作者信息

Osawa Hinata, Saito Kosuke, Demizu Yosuke

机构信息

Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Okayama Japan.

Division of Organic Chemistry, National Institute of Health Sciences Kanagawa Japan

出版信息

RSC Med Chem. 2025 Sep 2. doi: 10.1039/d5md00396b.

Abstract

Proteolysis-targeting chimeras (PROTACs) are emerging as powerful tools for targeted protein degradation. Among the key factors influencing their efficacy, linker design plays a critical role by affecting membrane permeability, ternary complex formation, and degradation potency. In this study, we conducted a comparative analysis of three novel PROTACs targeting hematopoietic prostaglandin D synthase (H-PGDS), each incorporating linkers with distinct degrees of rigidity-including methylene modifications and spirocyclic structures. Although all compounds exhibited similar binding affinities and degradation activities, the most rigid derivative (PROTAC-3) showed markedly higher intracellular accumulation but formed the least stable ternary complex. These results reveal a trade-off between cell permeability and complex stability, emphasizing the importance of comprehensive linker optimization. Our findings highlight the value of integrating conformational rigidity and spatial design in the rational development of next-generation PROTACs.

摘要

蛋白酶靶向嵌合体(PROTACs)正逐渐成为靶向蛋白质降解的有力工具。在影响其疗效的关键因素中,连接子设计通过影响膜通透性、三元复合物形成和降解效力发挥着关键作用。在本研究中,我们对三种靶向造血前列腺素D合酶(H-PGDS)的新型PROTACs进行了比较分析,每种PROTAC都包含具有不同刚性程度的连接子,包括亚甲基修饰和螺环结构。尽管所有化合物都表现出相似的结合亲和力和降解活性,但刚性最强的衍生物(PROTAC-3)显示出明显更高的细胞内积累,但形成的三元复合物最不稳定。这些结果揭示了细胞通透性和复合物稳定性之间的权衡,强调了全面优化连接子的重要性。我们的研究结果突出了在下一代PROTACs的合理开发中整合构象刚性和空间设计的价值。

相似文献

5
Advancing Design Strategy of PROTACs for Cancer Therapy.用于癌症治疗的PROTACs的先进设计策略
MedComm (2020). 2025 Jun 25;6(7):e70258. doi: 10.1002/mco2.70258. eCollection 2025 Jul.

本文引用的文献

1
Targeted protein degradation for cancer therapy.用于癌症治疗的靶向蛋白质降解
Nat Rev Cancer. 2025 Apr 25. doi: 10.1038/s41568-025-00817-8.
4
Characteristic roadmap of linker governs the rational design of PROTACs.连接子的特征路线图决定了PROTACs的合理设计。
Acta Pharm Sin B. 2024 Oct;14(10):4266-4295. doi: 10.1016/j.apsb.2024.04.007. Epub 2024 Apr 11.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验